Skip to main content

Table 3 Full hepatic and metabolic profile among group A versus group B

From: Association between non-alcoholic fatty liver disease and epicardial adipose tissue volume with cardiometabolic risk in coronary heart disease

 

Groups

T test

Group A

Group B

t

P value

ALT

Range

11–67

11–27

2.868

0.006*

Mean ± SD

26.295 ± 12.676

16.875 ± 5.377

AST

Range

12–67

11–25

3.498

0.001*

Mean ± SD

26.773 ± 11.620

16.250 ± 4.837

Alkaline phosphatase

Range

45–134

35–65

4.264

 < 0.001*

Mean ± SD

68.114 ± 17.276

48.375 ± 10.794

Gamma GT

Range

2–54

4–12

6.389

 < 0.001*

Mean ± SD

28.250 ± 12.920

7.375 ± 2.419

Fasting sugar

Range

80–400

100–250

0.722

0.473

Mean ± SD

199.455 ± 81.494

183.750 ± 49.244

HbA1C

Range

5–7.5

4.9–7.1

 − 0.163

0.871

Mean ± SD

6.277 ± 0.743

6.313 ± 0.737

T. cholesterol

Range

101–225

130–190

0.112

0.911

Mean ± SD

157.227 ± 27.606

156.375 ± 21.229

LDL

Range

45–147

90–105

 − 1.547

0.127

Mean ± SD

87.182 ± 23.695

96.500 ± 6.022

HDL

Range

25–62

43–50

 − 1.626

0.109

Mean ± SD

42.227 ± 10.046

46.375 ± 2.419

TG

Range

65–347

130–200

 − 2.887

0.005*

Mean ± SD

132.636 ± 44.186

166.250 ± 23.488

FIB-4

Range

0.39–2.98

0.41–1.5

1.729

0.089

Mean ± SD

1.100 ± 0.529

0.850 ± 0.386

NAFLD fibrosis scoring system

Range

 − 4.46–1.34

 − 3.73–0.06

1.039

0.303

Mean ± SD

 − 1.250 ± 1.290

 − 1.665 ± 1.568

  1. *mean significant